-
Objective of the study is to outline the characteristics of deep dissecting hematoma (DDH).
Archives of Dermatology (Dermatology) - Wed, 22 October 2008
http://archderm.ama-assn.org/
-
Photodynamic therapy with the specific treatment regimen employed produces statistically significant quantitative cutaneous molecular changes (eg, production of types I and III collagen) that are associated with improved appearance of the skin.
Archives of Dermatology (Dermatology) - Wed, 22 October 2008
http://archderm.ama-assn.org/
-
Use of the 3-mg drospirenone/20-µg ethinyl estradiol 24/4 combined oral contraceptive pill (OCP) is effective in significantly reducing acne lesion counts in girls and women aged 14 to 45 years.
Medscape (Dermatology) - Wed, 8 October 2008
http://www.medscape.com
-
The main changes in onychomycosis are nail thickening, discoloration, and onycholysis (separation of the nail plate from the nail bed).
British Medical Journal (Dermatology) - Thu, 17 July 2008
http://www.bmjjournals.com
-
The National Institute for Health and Clinical Excellence (NICE) has published guidance on the use of adalimumab for the treatment of psoriasis in adults.
National Institute for Health and Clinical Excellence (Dermatology) - Fri, 27 June 2008
http://www.nice.org.uk
-
Objectives of the study is to characterize patients with anogenital dermatitis referred for patch testing by the North American Contact Dermatitis Group, to identify common allergens, and to explore sex associations.
Archives of Dermatology (Dermatology) - Fri, 27 June 2008
http://archderm.ama-assn.org/
-
Psoriasis is more than just a skin disorder that might need treatment: it is an autoimmune disease, and in about 10 percent of cases the disorder will affect the joints, a condition known as psoriatic arthritis.
Baylor College of Medicine (Dermatology) - Fri, 13 June 2008
http://www.bcm.edu
-
It is not rare to find the presence of eczemas of unknown origin in older patients, so some French researchers have performed a trial to try to find out the possible etiology of these skin reactions, above all as to the chronic assumption of drugs.
MedNews (Dermatology) - Sun, 8 June 2008
http://mn.medsurfnews.com/
-
Two randomised controlled trials (PHOENIX 1 & 2) highlight the efficacy of the human monoclonal antibody ustekinumab at treating psoriasis.
The Lancet (Dermatology) - Thu, 22 May 2008
http://www.thelancet.com
-
A new treatment for plaque psoriasis has proven safe and effective in a phase III trial.
The Lancet (Dermatology) - Wed, 23 April 2008
http://www.thelancet.com